Mutation screening and association study of the neprilysin gene in sporadic Alzheimer's disease in Chinese persons

J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):301-6. doi: 10.1093/gerona/60.3.301.

Abstract

Neprilysin has been reported to be a major beta-amyloid peptide (Abeta)-degrading enzyme. The decreased expression and activity of it may contribute to the development of Alzheimer's disease by promoting the accumulation of Abeta. We used denaturing high-performance liquid chromatography to screen the neprilysin gene (NEP) for single nucleotide polymorphisms (SNPs) in 257 Chinese sporadic Alzheimer's disease patients and 242 cognitive normal controls. As a result, eight novel and one known SNP were identified. Three of them, -204G-->C in the promoter region, IVS17-294C-->T, and IVS22+36C-->A showed a significant association with Alzheimer's disease (p = .006,.017, and.003, respectively). Subsequent haplotype analysis provided further evidence of the association (global p < .0001 for the three SNPs mentioned above, and global p < .01 for the eight SNPs with rare allele frequency > 1%). These findings indicate that genetic variations within or extremely close to NEP might influence the susceptibility to Alzheimer's disease in Chinese persons.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics*
  • Base Sequence
  • China / epidemiology
  • Chromatography, High Pressure Liquid
  • Cohort Studies
  • Female
  • Gene Expression Regulation
  • Genetic Predisposition to Disease / epidemiology*
  • Genetic Testing / methods
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation*
  • Neprilysin / genetics*
  • Neprilysin / metabolism
  • Polymerase Chain Reaction
  • Probability
  • Promoter Regions, Genetic
  • Sensitivity and Specificity
  • Severity of Illness Index

Substances

  • Neprilysin